MannKind Corporation Slumps After FDA Approval

June 27, 2014 8:22 PM

18 0

by Michelle JonesJune 27, 2014, 4:20 pm

Investors have been excitedly waiting to hear that MannKind Corporation (NASDAQ:MNKD)’s diabetes drug has the approval of the Food and Drug Administration. Now that the news is finally here though, Wall Street doesn’t seem too happy—probably because of the warning the drug will carry when it goes to...

Read more

To category page